This HTML5 document contains 128 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q56288717
rdf:type
wikibase:Item
schema:description
im August 2012 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в серпні 2012 wetenschappelijk artikel
p:P577
wds:Q56288717-CEADC180-8795-4072-91CD-E0453ADE7913
wdt:P577
2012-08-01T00:00:00Z
p:P407
wds:Q56288717-0C104FD3-918F-4CF6-8902-E97343663788
wdt:P407
wd:Q1860
p:P2860
wds:Q56288717-CD5B36EF-BAFB-4A9A-9F78-CE495584D41E wds:Q56288717-8FCE349A-9E90-41BC-A79C-2B4BA6DDDFE6 wds:Q56288717-9C764472-D1A5-4796-B9BB-E6F2751B17D9 wds:Q56288717-A36ED192-634C-4C1E-8526-ECC3F908CAD9 wds:Q56288717-A92D480A-7F49-48ED-8FE5-814E7C0D9E5C wds:Q56288717-A99CC8FB-B1F5-49AF-A0D5-AD364AAD9256 wds:Q56288717-FBC094CD-52F0-4AD2-A5D9-CD3995CC87DF wds:Q56288717-DE79F418-ED4D-4F00-8270-E5583C7D9281 wds:Q56288717-EDF7728C-A79C-4A7C-9C56-1A650C430FF9 wds:Q56288717-F87C21EA-830D-4748-A9D2-06F97186E12B wds:Q56288717-00F4B6BA-F479-49F4-865A-455CC8A5161B wds:Q56288717-2B69E1CE-6D18-45AD-8E7E-DFA3583BD781 wds:Q56288717-2C507138-5AAB-497C-A627-6DA2A1A05747 wds:Q56288717-2F260A5F-1FB4-45F0-AE33-31E80DB9068C wds:Q56288717-3127C15F-8D50-4B87-9308-EDEF06B1724D wds:Q56288717-36438352-41B8-4B36-8847-3075BE263E2F wds:Q56288717-431D6793-A8CE-4264-B660-9BAD5F131A42 wds:Q56288717-4663BBEA-5A85-4D9F-A233-8ACDCB390D71 wds:Q56288717-4FC42774-88C1-41CE-A22B-937A38D0B9FA wds:Q56288717-08805516-C227-47D1-AF37-167B648EAC3B wds:Q56288717-091E004E-D90F-4D5D-9D68-F10C50A27547 wds:Q56288717-0B7F4D25-B762-4FDC-BC98-ACCFC3E31DC7 wds:Q56288717-15DE27A9-F181-4612-9602-C1B059B3C237 wds:Q56288717-724A1A7C-CBFC-47D0-9D78-F4414E57C7CD wds:Q56288717-7590B2C6-D773-4080-A6BB-47E9238534BE wds:Q56288717-7AAF42B9-D383-4321-813C-47543E677B36 wds:Q56288717-8B76722B-B66E-41DF-BC61-DEEBDB9F53E9 wds:Q56288717-56A0CE64-D2B4-410B-8593-AB69CE77486C wds:Q56288717-5E448945-B9C6-4056-AF83-32BF89A1E1D9 wds:Q56288717-5F58F847-A5DC-48AC-9F3B-F6597544FE13 wds:Q56288717-60DA61E2-C89E-4501-9AD2-C3E84A7AD5A1 wds:Q56288717-6955839D-1F3D-4A62-BD81-B5C79D89C1E5 wds:Q56288717-6E722C80-0332-4B91-A792-19501E28D3E8 wds:Q56288717-6E865818-8784-4D07-A3D3-87A193ED2CE1 wds:Q56288717-B7B873E7-E663-4B6C-A99F-B21EDF263972 wds:Q56288717-B896EE92-EECC-4622-AC03-EB27F06FAA78 wds:Q56288717-BA2F5BC7-475C-4A00-AD15-5360BDF3EB0A wds:Q56288717-BBDCC7CF-8BDE-4C49-BE17-96870F207259 wds:Q56288717-C404EFA1-AE0C-4906-AE05-2988F0568F64
wdt:P2860
wd:Q34423541 wd:Q36118055 wd:Q34657980 wd:Q40412943 wd:Q64449593 wd:Q81630825 wd:Q34186477 wd:Q79344278 wd:Q57769383 wd:Q34002283 wd:Q73544776 wd:Q47614092 wd:Q40403647 wd:Q38501067 wd:Q40662037 wd:Q40944402 wd:Q81729221 wd:Q56475155 wd:Q37132654 wd:Q44839892 wd:Q35126727 wd:Q34416409 wd:Q33795963 wd:Q40781967 wd:Q73221966 wd:Q34431941 wd:Q80140805 wd:Q73236467 wd:Q80179454 wd:Q73521140 wd:Q42848329 wd:Q80442563 wd:Q45262324 wd:Q53357010 wd:Q46191209 wd:Q83058106 wd:Q81460063 wd:Q46611466 wd:Q73318505
p:P2093
wds:Q56288717-F6DD4400-04A4-412B-A52D-866D18DFFE94 wds:Q56288717-DD715C5C-0AC0-45D5-854B-9C08B0BB7BCF wds:Q56288717-B75EFCDE-B6AB-480B-B027-95B83F037ED4 wds:Q56288717-9BFECA44-0B29-4C96-9C02-665FAEF40A17 wds:Q56288717-7006DCD1-9B6B-48D5-8EB3-4268E27919CB wds:Q56288717-0E986EC0-70C9-4EF2-9326-090354946262
wdt:P2093
Birgit Thierry-Carstensen Anders Mørup Jensen Charlotte Sørensen Carsten Heilmann Hilde Hylland Uhlving Karina Jordan
rdfs:label
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac
skos:prefLabel
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac
schema:name
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac
p:P50
wds:Q56288717-E0B12115-E22C-48DF-AC2B-0C1C7B70AC7D
wdt:P50
wd:Q57016518
p:P1476
wds:Q56288717-908B7E14-EFD1-4096-9DFE-B513B6E6037C
wdt:P1476
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac
p:P304
wds:Q56288717-A344C3BB-EA6B-486F-96D8-889B758D53EB
wdt:P304
5464-5471
p:P31
wds:Q56288717-89710EC1-060A-4EB9-AB33-9FE8ADB876D5
wdt:P31
wd:Q13442814
p:P921
wds:Q56288717-ED5FEEFC-C60C-4D88-ABC8-00A81B715A00
wdt:P921
wd:Q134808
p:P698
wds:Q56288717-07B9CC0A-BB35-4074-823C-73159B601E7E
wdtn:P698
n11:22776216
wdt:P698
22776216
p:P1433
wds:Q56288717-85CD68C3-0BBC-4719-94B7-5F96C81746B3
wdt:P1433
wd:Q7907941
p:P433
wds:Q56288717-DE79DBEC-827B-43E0-A525-962DB2E47FC0
p:P478
wds:Q56288717-1D73813A-DB67-4407-BC36-03B97F1B6279
wdt:P433
37
wdt:P478
30
p:P356
wds:Q56288717-7FC8945C-B4DF-430E-970F-982A3A2456E6
wdtn:P356
n12:J.VACCINE.2012.06.073
wdt:P356
10.1016/J.VACCINE.2012.06.073
p:P5875
wds:Q56288717-7E934EA8-A45A-4D67-89D8-9A366D8E3AF0
wdt:P5875
229009536